Developer docs
API playgroundTry for free, no card

Search company profiles

ArkGen

Full company profile

uuid002mr3j

Namestring
ArkGen
Legal namestring
ArkGen Pharma Private Limited
Company typeenum
Private
Founded yearstring
-
Descriptiontext

ArkGen Pharma Private Limited is a Bangalore-based, privately-held pharmaceutical company that researches, develops, and produces Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), Regulatory Starting Materials, and Related Substances for the global pharmaceutical industry. The company's commercial offering spans a portfolio of approximately 10 APIs (including Cabergoline, Valganciclovir Hydrochloride, Misoprostol, Levothyroxine Sodium, Brimonidine Tartrate, Fingolimod Hydrochloride, Rasagiline Mesylate, Olopatadine Hydrochloride, and Ripasudil Hydrochloride) and 15 KSMs, alongside a related-substances line of certified reference standards, impurities, and metabolites.

The company operates an asset-light manufacturing model, outsourcing production to contract partner Mavion Pharmasciences Pvt Ltd at a facility in Attibele Industrial Area, Bangalore, while retaining its R&D and regulatory capabilities in-house. Core technical competencies center on route scouting, process optimization, impurity profiling, and analytical method development aligned with ICH and global pharmacopeial standards (USP, IP, Ph.Eur, IH). ArkGen pairs its ingredient supply business with a regulatory services practice covering DMF preparation, ANDA lifecycle support, regulatory deficiency response, process development and scale-up, and technology transfer — positioning the company as a one-stop development partner for generic pharmaceutical manufacturers.

ArkGen monetizes through direct B2B sales of APIs and KSMs to formulation manufacturers (priced per project/order) and through professional services engagements for regulatory documentation and lifecycle support. The company targets two primary customer segments: large global pharmaceutical companies requiring compliant API supply, and generic manufacturers filing ANDAs who need both ingredients and regulatory support. The company serves 21 clients with 170 cumulative projects delivered over approximately five years, is FORM 37 accredited, and is led by Dr. P. M. Akbarali (Chairman & Managing Director), a pharmaceutical veteran with 36+ years of experience, 12 patents, and 25 scientific publications.

Short descriptiontext

ArkGen Pharma Private Limited is a Bangalore-based pharmaceutical company that develops and supplies Active Pharmaceutical Ingredients, Key Starting Materials, and regulatory support services to global pharmaceutical and generic-drug manufacturers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBangalore, India
HQ citystring
Bangalore
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
active pharmaceutical ingredients, key starting materials, pharmaceutical contract manufacturing, regulatory support services, drug development services
Industry4 codes
PRIMARYHLAGAHAB
Small-Molecule API Commercial Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code1 code
  • Pharmaceutical and Medicine Manufacturing3254
SIC code2 codes
  • Industrial Organic Chemicals2860
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical API Manufacturing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1API Sales
TypeOne Time License
Description

Sale of Active Pharmaceutical Ingredients to pharmaceutical manufacturers for formulation into finished dosage forms

arkgenpharma.com
2KSM Sales
TypeOne Time License
Description

Sale of Key Starting Materials and Regulatory Starting Materials for pharmaceutical manufacturing

arkgenpharma.com
3Regulatory Services
TypeProfessional Services
Description

DMF preparation and support, ANDA lifecycle support, regulatory deficiency responses, and technology transfer services

arkgenpharma.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

ArkGen Pharma researches, develops, and manufactures Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), Regulatory Starting Materials, and Related Substances for global pharmaceutical formulation manufacturers. The company supplies a portfolio of 10+ named APIs and 15+ KSMs, complemented by end-to-end regulatory support services including DMF preparation, ANDA lifecycle support, regulatory deficiency responses, process development and scale-up, and technology transfer. Operations follow ICH guidelines and FORM 37 accreditation, with manufacturing conducted through partner facility Mavion Pharmasciences Pvt Ltd.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 170 projects successfully delivered
+1 more record
Product overview1 text field

ArkGen Pharma is a research-driven pharmaceutical company specializing in Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), Regulatory Starting Materials, and Related Substances. The company offers a portfolio of 10+ named APIs and 15+ KSMs, supported by comprehensive regulatory services including DMF preparation and support, ANDA lifecycle support, regulatory deficiency responses, process development and scale-up, and technology transfer. The product portfolio includes therapeutic APIs such as Cabergoline, Valganciclovir, Misoprostol, Levothyroxine Sodium, Brimonidine Tartrate, Fingolimod Hydrochloride, Rasagiline Mesylate, Olopatadine Hydrochloride, and Ripasudil Hydrochloride, alongside various API intermediates and pharmaceutical intermediates.

Product and service16 records
1CABERGOLINE USP / IP / Ph.Eur
CategoryActive Pharmaceutical Ingredient
Description

API product compliant with USP, IP, and Ph.Eur pharmacopeial standards for use in pharmaceutical formulation manufacturing.

2VALGANCICLOVIR HYDROCHLORIDE USP
CategoryActive Pharmaceutical Ingredient
Description

Antiviral API product compliant with USP standards for use in pharmaceutical formulation manufacturing.

3MISOPROSTOL USP 1% HPMC
CategoryActive Pharmaceutical Ingredient
Description

API product in 1% HPMC formulation, compliant with USP standards for pharmaceutical formulation manufacturing.

4LEVOTHYROXINE SODIUM USP / IP
CategoryActive Pharmaceutical Ingredient
Description

Thyroid hormone API compliant with USP and IP pharmacopeial standards for pharmaceutical formulation manufacturing.

5PYRIDOXAMINE DIHYDROCHLORIDE IH
CategoryActive Pharmaceutical Ingredient
Description

Vitamin B6 derivative API for pharmaceutical applications and formulation manufacturing.

6NEPAFENAC IH / USP
CategoryActive Pharmaceutical Ingredient
Description

NSAID API compliant with IH and USP standards for ophthalmic pharmaceutical formulation manufacturing.

7BRIMONIDINE TARTRATE Ph.Eur
CategoryActive Pharmaceutical Ingredient
Description

Alpha-2 adrenergic agonist API compliant with European Pharmacopoeia for pharmaceutical formulation manufacturing.

8FINGOLIMOD HYDROCHLORIDE
CategoryActive Pharmaceutical Ingredient
Description

Immunosuppressant API for multiple sclerosis treatment in pharmaceutical formulation manufacturing.

9RASAGILINE MESYLATE
CategoryActive Pharmaceutical Ingredient
Description

MAO-B inhibitor API for Parkinson's disease treatment in pharmaceutical formulation manufacturing.

10OLOPATADINE HYDROCHLORIDE USP
CategoryActive Pharmaceutical Ingredient
Description

Antihistamine API for allergic rhinitis and conjunctivitis treatment in pharmaceutical formulation manufacturing.

11RIPASUDIL HYDROCHLORIDE HYDRATE IH
CategoryActive Pharmaceutical Ingredient
Description

Rho-associated protein kinase inhibitor API for glaucoma treatment in pharmaceutical formulation manufacturing.

12DMF preparation and support
CategoryRegulatory Support Service
Description

End-to-end regulatory and process development support for Drug Master File preparation and submission, offered to pharmaceutical manufacturers.

13ANDA lifecycle support
CategoryRegulatory Support Service
Description

Comprehensive DMF, ANDA, and Technology Transfer assistance throughout the product lifecycle for pharmaceutical manufacturers.

14Regulatory deficiency responses
CategoryRegulatory Support Service
Description

Full lifecycle support for addressing regulatory deficiencies in pharmaceutical development processes for pharmaceutical manufacturers.

15Process development and scale-up
CategoryPharmaceutical Development Service
Description

Regulatory, development, and scale-up expertise for transitioning processes from R&D to commercial production, offered to pharmaceutical manufacturers.

16Technology transfer
CategoryPharmaceutical Development Service
Description

Complete support for pharmaceutical process and compliance during technology transfer operations for pharmaceutical manufacturers.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Mavion Pharmasciences Pvt Ltd
Strategic tierCoreTypeOthers
Description

Mavion Pharmasciences Pvt Ltd serves as the manufacturing site for ArkGen Pharma. The facility is located at Plot No. 11/2, Attibele Industrial Area, Balagaranahalli, Anekal Taluk, Bangalore – 562 107, Karnataka, India.

arkgenpharma.com
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Large Indian CDMO offering API development and manufacturing, including DMF/CMC support, across multiple therapeutic areas. Operates in the same space as ArkGen but at greater scale, making it a scaled-up comparable.

TypeBroad incumbent
Description

Indian CDMO offering APIs, intermediates, and contract development services to global pharma. Overlaps with ArkGen on API development and regulatory support, but with significantly broader scale and an established CDMO platform.

TypeBroad incumbent
Description

Indian pharmaceutical company with active pharmaceutical ingredient manufacturing for global generics markets. Comparable in API focus and customer segment, though operates at much greater scale and with finished dosage capabilities.

TypeBroad incumbent
Description

Indian API manufacturer specializing in generics APIs and intermediates with strong global regulatory footprint. Comparable in API/intermediates work, though much larger and more focused on a narrower set of molecules.

TypeDirect peer
Description

India-headquartered CDMO providing API process development, analytical services, and regulatory support to global pharma companies. Directly comparable service mix (development + regulatory + scale-up) and target customers overlap with ArkGen.

TypeBroad incumbent
Description

Vertically integrated Indian pharmaceutical major with significant small-molecule API operations supplying global generics markets. Overlaps on APIs like Levothyroxine and Valganciclovir, but operates at vastly larger scale across finished dosage forms too.

TypeDirect peer
Description

Indian CDMO and small-molecule API manufacturer offering contract development, regulatory support (DMF/ANDA), and commercial API supply. Highly comparable business model to ArkGen with similar therapeutic breadth and customer base of generic pharma firms.

8Syngene International
TypeEmerging player
Description

Indian CRO/CDMO offering development and analytical services to global pharma. While more discovery-research oriented than ArkGen, it competes for the same 'India-based outsourced pharma services' wallet and demonstrates the broader India CDMO positioning ArkGen is targeting.

TypeBroad incumbent
Description

One of India's leading API manufacturers with a broad small-molecule API portfolio across antivirals, oncology, and ophthalmology — several of which overlap with ArkGen's product list. Larger scale and broader geographic reach make it an incumbent benchmark rather than a like-for-like competitor.

10Apotex Pharmachem India
TypeRegional player
Description

Indian subsidiary of Canada's Apotex (where CMD Dr. P.M. Akbarali previously served as Managing Director). Directly relevant given the leadership lineage and operates in the same small-molecule API + regulatory support segment with a global generics customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ArkGen

Pharmaceutical API Manufacturingarkgenpharma.com

ArkGen Pharma Private Limited is a Bangalore-based pharmaceutical company that develops and supplies Active Pharmaceutical Ingredients, Key Starting Materials, and regulatory support services to global pharmaceutical and generic-drug manufacturers.

What ArkGen does

ArkGen Pharma Private Limited is a Bangalore-based, privately-held pharmaceutical company that researches, develops, and produces Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), Regulatory Starting Materials, and Related Substances for the global pharmaceutical industry. The company's commercial offering spans a portfolio of approximately 10 APIs (including Cabergoline, Valganciclovir Hydrochloride, Misoprostol, Levothyroxine Sodium, Brimonidine Tartrate, Fingolimod Hydrochloride, Rasagiline Mesylate, Olopatadine Hydrochloride, and Ripasudil Hydrochloride) and 15 KSMs, alongside a related-substances line of certified reference standards, impurities, and metabolites.

The company operates an asset-light manufacturing model, outsourcing production to contract partner Mavion Pharmasciences Pvt Ltd at a facility in Attibele Industrial Area, Bangalore, while retaining its R&D and regulatory capabilities in-house. Core technical competencies center on route scouting, process optimization, impurity profiling, and analytical method development aligned with ICH and global pharmacopeial standards (USP, IP, Ph.Eur, IH). ArkGen pairs its ingredient supply business with a regulatory services practice covering DMF preparation, ANDA lifecycle support, regulatory deficiency response, process development and scale-up, and technology transfer — positioning the company as a one-stop development partner for generic pharmaceutical manufacturers.

ArkGen monetizes through direct B2B sales of APIs and KSMs to formulation manufacturers (priced per project/order) and through professional services engagements for regulatory documentation and lifecycle support. The company targets two primary customer segments: large global pharmaceutical companies requiring compliant API supply, and generic manufacturers filing ANDAs who need both ingredients and regulatory support. The company serves 21 clients with 170 cumulative projects delivered over approximately five years, is FORM 37 accredited, and is led by Dr. P. M. Akbarali (Chairman & Managing Director), a pharmaceutical veteran with 36+ years of experience, 12 patents, and 25 scientific publications.

ArkGen firmographics

Firmographics
Name
ArkGen
Legal name
ArkGen Pharma Private Limited
Website
https://arkgenpharma.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
ArkGen Pharma Private Limited is a Bangalore-based pharmaceutical company that develops and supplies Active Pharmaceutical Ingredients, Key Starting Materials, and regulatory support services to global pharmaceutical and generic-drug manufacturers.
Ownership category
akta.pro rank

ArkGen industry classification

Industry
Product category
Pharmaceutical API Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (3254)
SIC
Industrial Organic Chemicals (2860), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAHAB
Small-Molecule API Commercial Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Active pharmaceutical ingredients
  • Key starting materials
  • Pharmaceutical contract manufacturing
  • Regulatory support services
  • Drug development services

Where ArkGen is headquartered

Location

Headquarters

HQ city
Bangalore
HQ country
India
HQ region
Asia

Offices2 records

Markets served

ArkGen business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. API Sales: Sale of Active Pharmaceutical Ingredients to pharmaceutical manufacturers for formulation into finished dosage forms
  2. KSM Sales: Sale of Key Starting Materials and Regulatory Starting Materials for pharmaceutical manufacturing
  3. Regulatory Services: DMF preparation and support, ANDA lifecycle support, regulatory deficiency responses, and technology transfer services

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

ArkGen product offering

Product offering

Core offering

ArkGen Pharma researches, develops, and manufactures Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), Regulatory Starting Materials, and Related Substances for global pharmaceutical formulation manufacturers. The company supplies a portfolio of 10+ named APIs and 15+ KSMs, complemented by end-to-end regulatory support services including DMF preparation, ANDA lifecycle support, regulatory deficiency responses, process development and scale-up, and technology transfer. Operations follow ICH guidelines and FORM 37 accreditation, with manufacturing conducted through partner facility Mavion Pharmasciences Pvt Ltd.

Product overview

ArkGen Pharma is a research-driven pharmaceutical company specializing in Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), Regulatory Starting Materials, and Related Substances. The company offers a portfolio of 10+ named APIs and 15+ KSMs, supported by comprehensive regulatory services including DMF preparation and support, ANDA lifecycle support, regulatory deficiency responses, process development and scale-up, and technology transfer. The product portfolio includes therapeutic APIs such as Cabergoline, Valganciclovir, Misoprostol, Levothyroxine Sodium, Brimonidine Tartrate, Fingolimod Hydrochloride, Rasagiline Mesylate, Olopatadine Hydrochloride, and Ripasudil Hydrochloride, alongside various API intermediates and pharmaceutical intermediates.

Differentiator

Problem solved

Functional benefit

Products and services

  • CABERGOLINE USP / IP / Ph.Eur API product compliant with USP, IP, and Ph.Eur pharmacopeial standards for use in pharmaceutical formulation manufacturing.
  • VALGANCICLOVIR HYDROCHLORIDE USP Antiviral API product compliant with USP standards for use in pharmaceutical formulation manufacturing.
  • MISOPROSTOL USP 1% HPMC API product in 1% HPMC formulation, compliant with USP standards for pharmaceutical formulation manufacturing.
  • LEVOTHYROXINE SODIUM USP / IP Thyroid hormone API compliant with USP and IP pharmacopeial standards for pharmaceutical formulation manufacturing.
  • PYRIDOXAMINE DIHYDROCHLORIDE IH Vitamin B6 derivative API for pharmaceutical applications and formulation manufacturing.
  • NEPAFENAC IH / USP NSAID API compliant with IH and USP standards for ophthalmic pharmaceutical formulation manufacturing.
  • BRIMONIDINE TARTRATE Ph.Eur Alpha-2 adrenergic agonist API compliant with European Pharmacopoeia for pharmaceutical formulation manufacturing.
  • FINGOLIMOD HYDROCHLORIDE Immunosuppressant API for multiple sclerosis treatment in pharmaceutical formulation manufacturing.
  • RASAGILINE MESYLATE MAO-B inhibitor API for Parkinson's disease treatment in pharmaceutical formulation manufacturing.
  • OLOPATADINE HYDROCHLORIDE USP Antihistamine API for allergic rhinitis and conjunctivitis treatment in pharmaceutical formulation manufacturing.
  • RIPASUDIL HYDROCHLORIDE HYDRATE IH Rho-associated protein kinase inhibitor API for glaucoma treatment in pharmaceutical formulation manufacturing.
  • DMF preparation and support End-to-end regulatory and process development support for Drug Master File preparation and submission, offered to pharmaceutical manufacturers.
  • ANDA lifecycle support Comprehensive DMF, ANDA, and Technology Transfer assistance throughout the product lifecycle for pharmaceutical manufacturers.
  • Regulatory deficiency responses Full lifecycle support for addressing regulatory deficiencies in pharmaceutical development processes for pharmaceutical manufacturers.
  • Process development and scale-up Regulatory, development, and scale-up expertise for transitioning processes from R&D to commercial production, offered to pharmaceutical manufacturers.
  • Technology transfer Complete support for pharmaceutical process and compliance during technology transfer operations for pharmaceutical manufacturers.

Quantifiable outcome

  • 170 projects successfully delivered
  • +1 more outcomes

Companies that use ArkGen

Customer profile

Segments2 records

Ideal customer profiles2 records

ArkGen technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

ArkGen partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Mavion Pharmasciences Pvt LtdcoreOthersMavion Pharmasciences Pvt Ltd serves as the manufacturing site for ArkGen Pharma. The facility is located at Plot No. 11/2, Attibele Industrial Area, Balagaranahalli, Anekal Taluk, Bangalore – 562 107, Karnataka, India.

Scale indicators7 records

Recent moves1 record

Expansion highlights4 records

ArkGen competitors and assessment

Company assessment

Direct peers

  • Piramal Pharma Solutions: Large Indian CDMO offering API development and manufacturing, including DMF/CMC support, across multiple therapeutic areas. Operates in the same space as ArkGen but at greater scale, making it a scaled-up comparable.
  • Sai Life Sciences: India-headquartered CDMO providing API process development, analytical services, and regulatory support to global pharma companies. Directly comparable service mix (development + regulatory + scale-up) and target customers overlap with ArkGen.
  • Neuland Laboratories: Indian CDMO and small-molecule API manufacturer offering contract development, regulatory support (DMF/ANDA), and commercial API supply. Highly comparable business model to ArkGen with similar therapeutic breadth and customer base of generic pharma firms.

Broad incumbents

  • Jubilant Ingrevia: Indian CDMO offering APIs, intermediates, and contract development services to global pharma. Overlaps with ArkGen on API development and regulatory support, but with significantly broader scale and an established CDMO platform.
  • Granules India: Indian pharmaceutical company with active pharmaceutical ingredient manufacturing for global generics markets. Comparable in API focus and customer segment, though operates at much greater scale and with finished dosage capabilities.
  • Divis Laboratories: Indian API manufacturer specializing in generics APIs and intermediates with strong global regulatory footprint. Comparable in API/intermediates work, though much larger and more focused on a narrower set of molecules.
  • Aurobindo Pharma: Vertically integrated Indian pharmaceutical major with significant small-molecule API operations supplying global generics markets. Overlaps on APIs like Levothyroxine and Valganciclovir, but operates at vastly larger scale across finished dosage forms too.
  • Laurus Labs: One of India's leading API manufacturers with a broad small-molecule API portfolio across antivirals, oncology, and ophthalmology — several of which overlap with ArkGen's product list. Larger scale and broader geographic reach make it an incumbent benchmark rather than a like-for-like competitor.

Emerging players

  • Syngene International: Indian CRO/CDMO offering development and analytical services to global pharma. While more discovery-research oriented than ArkGen, it competes for the same 'India-based outsourced pharma services' wallet and demonstrates the broader India CDMO positioning ArkGen is targeting.

Regional players

  • Apotex Pharmachem India: Indian subsidiary of Canada's Apotex (where CMD Dr. P.M. Akbarali previously served as Managing Director). Directly relevant given the leadership lineage and operates in the same small-molecule API + regulatory support segment with a global generics customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

ArkGen social profiles

Digital presence

ArkGen compliance and trust

Trust signal

Compliance2 records

ArkGen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ArkGen leadership team

Management profile

Number of profiles

Profiles3 records

ArkGen funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ArkGen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ArkGen

What does ArkGen do?

ArkGen Pharma researches, develops, and manufactures Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), Regulatory Starting Materials, and Related Substances for global pharmaceutical formulation manufacturers. The company supplies a portfolio of 10+ named APIs and 15+ KSMs, complemented by end-to-end regulatory support services including DMF preparation, ANDA lifecycle support, regulatory deficiency responses, process development and scale-up, and technology transfer. Operations follow ICH guidelines and FORM 37 accreditation, with manufacturing conducted through partner facility Mavion Pharmasciences Pvt Ltd.

Is ArkGen a public or private company?

ArkGen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ArkGen founded?

ArkGen was founded in -1. It employs 11 to 50 people.

Where is ArkGen based?

ArkGen is headquartered in Bangalore, India, in the Asia region.

How does ArkGen make money?

Three revenue lines are on record. API Sales are the primary driver. The others are KSM Sales and regulatory Services.

Who are ArkGen's main competitors?

Direct peers on record are Piramal Pharma Solutions, Sai Life Sciences and Neuland Laboratories. Broad incumbents are Jubilant Ingrevia, Granules India, Divis Laboratories, Aurobindo Pharma and Laurus Labs. Syngene International is listed as an emerging player. Apotex Pharmachem India is listed as a regional player.

Does ArkGen have an API?

No public API is recorded for ArkGen.

What industry is ArkGen in?

ArkGen's product category is Pharmaceutical API Manufacturing. Its primary akta.pro industry code is HLAGAHAB, Small-Molecule API Commercial Manufacturing, with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 3254 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales